Yahoo Search Busca da Web

Entrar

Resultado da Busca

  1. www.fortunebusinessinsights.com › industry-reportsColorectal Cancer Therapeutics Market Size, Share & Report, 2032

    13 de mai. de 2024 · Listen to Audio Version. The global colorectal cancer therapeutics market size stood at USD 9.26 billion in 2018 and is projected to reach USD 26.49 billion by 2032, exhibiting a CAGR of 7.8% during the forecast period. In this era, the prevalence of critical and life-threatening diseases has been increasing across the global landscape.

  2. www.delveinsight.com › report-store › metastaticMetastatic Colorectal Cancer (mCRC) Epidemiology Forecast ...

    Metastatic Colorectal Cancer (mCRC) epidemiology report gives a thorough understanding of the Metastatic Colorectal Cancer (mCRC) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis.

  3. www.linkedin.com › pulse › metastatic-colorectalMetastatic Colorectal Cancer Treatment Market Size, Report ...

    9 de mai. de 2024 · 3 Market Competition, by Players 3.1 Global Metastatic Colorectal Cancer Treatment Revenue and Share by Players (2019,2020,2021,2022,2023 and 2024) 3.2 Market Concentration Rate 3.2.1 Top3 ...

  4. www.ncbi.nlm.nih.gov › pmc › articlesMechanisms of Metastasis in Colorectal Cancer and Metastatic ...

    19 de set. de 2019 · In breast cancer, apart from cancer subtype and gene signature, metastatic organotropism was found to be regulated by molecular features such as chemokines and integrins. Binding of the chemokine CXCL12 to its receptor CXCR4 is associated with induction of liver metastasis and facilitates extravasation of tumor cells.

  5. seer.cancer.gov › statfacts › htmlColorectal Cancer — Cancer Stat Facts

    Rates of new cases are also referred to as incidence rates. Rate of New Cases and Deaths per 100,000: The rate of new cases of colorectal cancer was 36.5 per 100,000 men and women per year. The death rate was 12.9 per 100,000 men and women per year. These rates are age-adjusted and based on 2017–2021 cases and 2018–2022 deaths.

  6. thelansis.com › reports › relapsed-or-refractoryRelapsed or Refractory Metastatic Colorectal Cancer - THELANSIS

    24 de set. de 2021 · Thelansis’s “Relapsed or Refractory Metastatic Colorectal Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under ...

  7. www.researchandmarkets.com › reports › 5524611Colorectal Cancer (CRC) - Epidemiology Forecast to 2032

    This "Colorectal Cancer (CRC) - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Colorectal...